VOLITIONRX LTD — Director's Dealing 2016

May 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-05-20

Reporting Person: Reynolds Cameron John (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-20	Common Stock	M	20000	$3	Acquired	1125016	Direct
2016-05-20	Common Stock	F	16950	$3.54	Disposed	1108066	Direct
2016-05-20	Common Stock	X	4000	$3	Acquired	32287	Indirect
2016-05-20	Common Stock	S	3390	$3.54	Disposed	28897	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-20	Stock Option (Right to Buy)	$3	M	20000	Disposed	2016-05-25	Common Stock (20000)	Direct
2016-05-20	Stock Option (Right to Buy)	$3	X	4000	Disposed	2016-05-25	Common Stock (4000)	Indirect

Footnotes

F1: Represents the aggregate amount of shares of VolitionRx Limited Common Stock disposed of in a cashless exercise.